Security
NUTX · Nutex Health Inc.
NUTXNASDAQCommon stockCurrentCIK 1479681Updated Sep 24, 2026
Name history
Nutex Health, Inc. · through Feb 11, 2026Clinigence Holdings, Inc. · through Mar 31, 2022iGambit, Inc. · through Nov 13, 2019
NUTX price & chart
Loading TradingView…
NASDAQ:NUTX on TradingView ↗About the company
Headquartered in Houston, Texas and founded in 2011, Nutex Health Inc. is a healthcare management and operations company with two divisions: a Hospital Division and a Population Health Management Division. The Hospital Division owns, develops and operates innovative health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 24 facilities in 11 states.
In the news
Kuehn Law Encourages Investors of Nutex Health, Inc. to Contact Law Firm ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX ↗
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health, Inc. - NUTX ↗
Recent filings
CERT filing
8-A12B filing
Other Events
Items 8.01, 9.01
8-K filing
Other Events
Items 8.01
Show 5 more recent filings
Other Events
Items 8.01
Results of Operations and Financial Condition
Items 2.02, 9.01
10-Q filing
4 filing
Entry into a Material Definitive Agreement
Items 1.01
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 918,525,000Source | 655,320,393Source | 398,245,497Source | 431,751,985Source |
| Property, Plant and Equipment, NetUSD | 94,581,000Source | 77,932,744Source | 81,387,649Source | 82,094,352Source |
| GoodwillUSD | 13,919,000Source | 13,918,719Source | 17,066,263Source | 17,010,637Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 21,230,000Source | 15,530,281Source | 20,512,636Source | 21,191,390Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 185,574,000Source | 40,640,616Source | 22,002,056Source | 34,255,264Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | — | 232,449,226Source | 58,624,301Source | 57,777,386Source |
| Inventory, NetUSD | 2,866,000Source | 2,849,814Source | 3,390,584Source | 3,533,285Source |
| Assets, CurrentUSD | 538,811,000Source | 292,478,885Source | 90,848,403Source | 97,973,924Source |
| Prepaid Expense and Other Assets, CurrentUSD | 24,656,000Source | 9,996,244Source | 2,679,394Source | 1,869,806Source |
| Operating Lease, Right-of-Use AssetUSD | 26,955,000Source | 27,871,830Source | 11,853,082Source | 20,466,632Source |
| Other Assets, NoncurrentUSD | 662,000Source | — | — | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 495,088,000Source | 466,788,581Source | 319,139,391Source | 311,424,585Source |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 7,000Source | 5,511Source | 676,680Source | 650,224Source |
| Additional Paid in CapitalUSD | 615,627,000Source | 489,408,981Source | 469,849,049Source | 458,498,402Source |
| Retained Earnings (Accumulated Deficit)USD | -286,187,000Source | -356,976,499Source | -409,072,539Source | -363,285,925Source |
| Stockholders' Equity Attributable to ParentUSD | 329,447,000Source | 132,437,993Source | 61,453,190Source | 95,862,701Source |
| Liabilities and EquityUSD | 918,525,000Source | 655,320,393Source | 398,245,497Source | 431,751,985Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 157,911,000Source | 154,226,190Source | 58,313,052Source | 54,862,969Source |
| Operating Lease, Liability, CurrentUSD | 2,152,000Source | 2,079,940Source | 1,579,987Source | 1,703,014Source |
| Accounts Payable, CurrentUSD | — | 9,613,821Source | 18,899,196Source | 23,614,387Source |
| Operating Lease, Liability, NoncurrentUSD | 30,037,000Source | 30,617,399Source | 15,479,639Source | 19,438,497Source |
| Deferred Income Tax Liabilities, NetUSD | 9,089,000Source | 0Source | 5,145,754Source | 10,452,211Source |
| Other Liabilities, NoncurrentUSD | — | 312,562,391Source | — | — |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 93,990,000Source | 56,093,819Source | 17,652,916Source | 24,464,699Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 9,089,000Source | — | 5,145,754Source | 10,452,211Source |
| Long-term Debt, Current MaturitiesUSD | 13,336,000Source | 14,395,457Source | 10,808,721Source | 12,546,097Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 29,174,000Source | 22,465,896Source | 26,314,733Source | 23,051,152Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | 180,357,000Source | 94,805,484Source | -43,423,715Source | -432,739,618Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 20,530,000Source | 18,971,972Source | 17,591,572Source | 13,131,374Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | 189,581Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | — | 173,956,924Source | 969,761Source | -56,622,133Source |
| Increase (Decrease) in InventoriesUSD | 16,000Source | -540,770Source | -142,701Source | 719,107Source |
| Deferred Income Tax Expense (Benefit)USD | 17,076,000Source | -13,132,990Source | -5,707,323Source | 4,996,209Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | 248,125,000Source | 23,153,807Source | 1,256,452Source | 50,607,108Source |
| Cash flows from investing activities: | ||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | 0Source | 0Source | 703,893Source | — |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -5,242,000Source | -5,606,018Source | -11,239,882Source | -4,337,398Source |
| Payments for (Proceeds from) Other Investing ActivitiesUSD | — | 2,665,222Source | — | — |
| Payments to Acquire Property, Plant, and EquipmentUSD | 2,526,000Source | 2,303,897Source | — | 14,632,414Source |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | 5,000,000Source | — | — | — |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | -97,949,000Source | 1,090,771Source | -2,269,778Source | -48,132,730Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 185,871,000Source | 40,640,616Source | — | — |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 2,508,000Source | 3,471,708Source | 1,639,044Source | 4,622,106Source |
| Income Taxes Paid, NetUSD | 72,815,000Source | 798,990Source | 849,358Source | 8,233,000Source |
| Additional Financial Items | ||||
| Accretion ExpenseUSD | 902,000Source | 1,042,663Source | 1,209,981Source | 1,902,475Source |
| Share-based Payment Arrangement, ExpenseUSD | 107,785,000Source | -129,743Source | — | — |
| Amortization of Debt Issuance CostsUSD | — | — | — | 50,354Source |
| Amortization of Intangible AssetsUSD | 1,300,000Source | 1,500,000Source | 1,600,000Source | 1,159,259Source |
| Deconsolidation, Gain (Loss), AmountUSD | — | — | 0Source | 0Source |
| Gain (Loss) on Termination of LeaseUSD | 0Source | 0Source | -58,210Source | — |
| General and Administrative ExpenseUSD | 51,653,000Source | 41,923,972Source | 33,229,718Source | 18,030,832Source |
| GoodwillUSD | 13,919,000Source | 13,918,719Source | 17,066,263Source | 17,010,637Source |
| Goodwill, Impairment LossUSD | 0Source | 3,197,391Source | — | 398,135,038Source |
| Impairment of Intangible Assets (Excluding Goodwill)USD | 0Source | 3,887,216Source | — | — |
| Impairment of Intangible Assets, Finite-livedUSD | — | — | 3,800,000Source | — |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill)USD | — | 3,900,000Source | 700,000Source | — |
| Income Tax Expense (Benefit)USD | 64,424,000Source | 15,020,258Source | -5,067,084Source | 13,090,905Source |
| InterestExpenseNonoperatingUSD | 22,226,000Source | 19,932,015Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | 70,789,000Source | 52,096,040Source | -45,786,614Source | -424,780,446Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 109,568,000Source | 42,709,444Source | 2,362,899Source | -7,959,172Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 70,789,000Source | 52,096,040Source | — | — |
| Operating ExpensesUSD | 168,656,000Source | 65,563,477Source | 66,547,919Source | 420,051,536Source |
| Other Nonoperating Income (Expense)USD | -8,618,000Source | 668,930Source | -399,182Source | -559,299Source |
| Proceeds from Issuance of Common StockUSD | 0Source | 9,202,500Source | — | — |
| Proceeds from Stock Options ExercisedUSD | — | 0Source | — | 644,974Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 875,257,000Source | 479,948,633Source | 247,646,316Source | 219,294,306Source |
| Operating Income (Loss)USD | 275,625,000Source | 130,697,800Source | -31,773,748Source | -406,599,154Source |
| Other Nonoperating Income (Expense)USD | -8,618,000Source | 668,930Source | -399,182Source | -559,299Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | 244,781,000Source | 109,825,742Source | -48,490,799Source | -419,648,713Source |
| Income Tax Expense (Benefit)USD | 64,424,000Source | 15,020,258Source | -5,067,084Source | 13,090,905Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | 109,568,000Source | 42,709,444Source | 2,362,899Source | -7,959,172Source |
| Net Income (Loss) Attributable to ParentUSD | 70,789,000Source | 52,096,040Source | -45,786,614Source | -424,780,446Source |
| Earnings Per Share, BasicUSD per share | 11.13Source | 10.23Source | -0.07Source | -0.67Source |
| Earnings Per Share, DilutedUSD per share | 10.48Source | 9.69Source | -0.07Source | -0.67Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 6,361,427Source | 5,090,787Source | 661,247,959Source | 634,877,629Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 6,756,108Source | 5,491,676Source | — | — |
| Interest Expense (non-operating)USD | 22,226,000Source | 19,932,015Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 1,300,000Source | 1,500,000Source | 1,600,000Source | 1,159,259Source |
| Business Combination, Acquisition Related CostsUSD | 0Source | 0Source | 43,464Source | 3,900,000Source |
| Costs and ExpensesUSD | 430,976,000Source | 283,687,356Source | 212,872,145Source | 205,841,924Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | 18,971,972Source | 17,591,572Source | 13,131,374Source |
| General and Administrative ExpenseUSD | 51,653,000Source | 41,923,972Source | 33,229,718Source | 18,030,832Source |
| Goodwill, Impairment LossUSD | 0Source | 3,197,391Source | — | 398,135,038Source |
| Gross ProfitUSD | 444,281,000Source | 196,261,277Source | 34,774,171Source | 13,452,382Source |
| Interest ExpenseUSD | — | — | 16,317,869Source | 12,490,260Source |
| Labor and Related ExpenseUSD | 158,081,000Source | 117,527,022Source | 108,377,938Source | — |
| Marketing and Advertising ExpenseUSD | 6,500,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 70,789,000Source | 52,096,040Source | — | — |
| Operating ExpensesUSD | 168,656,000Source | 65,563,477Source | 66,547,919Source | 420,051,536Source |
| Other Cost and Expense, OperatingUSD | — | 49,008,579Source | — | — |
| Other ExpensesUSD | 44,809,000Source | 31,145,690Source | 30,401,513Source | 30,413,069Source |
Filing attachments
a20251020-xfinmetricsxex991.htm · 8-K · 2025-10-20
EX-99.1 2 a20251020-xfinmetricsxex991.htm EX-99.1 Document NUTEX HEALTH PROVIDES CORPORATE UPDATE Significant Year-over-Year Growth in Patient Volume and Cash Collections HOUSTON, TX − (PRNewswire) - OCTOBER 20, 2025 - Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician netw…
Read attachment ↗ex991-bamburgpr.htm · 8-K · 2025-09-22
EX-99.1 3 ex991-bamburgpr.htm EX-99.1 Document Exhibit 99.1 NUTEX HEALTH ANNOUNCES THE APPOINTMENT OF WESLEY BAMBURG AS ITS NEW CHIEF OPERATING OFFICER HOUSTON, Sept. 22, 2025 - Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric, risk-bearing physician networks, today announced the appointment of …
Read attachment ↗